Phase 1
HealthyPhase 1Recruiting

๋™ํ™”์•ฝํ’ˆ - DW6025

Trial start date
2026.09.07D-12
Trial site์„œ์šธ ๋ถ€๋ฏผ๋ณ‘์› ๋ฏธ๋ž˜์˜ํ•™์„ผํ„ฐ์„œ์šธ ๊ฐ•์„œ๊ตฌ ๊ณตํ•ญ๋Œ€๋กœ 375 1์ธต ์ž„์ƒ์‹œํ—˜์„ผํ„ฐ
Screening period2026.08.11 ~ 2026.08.22(Choose date/time when applying)
Trial end date2026.09.20
Trial schedule

2๋ฐ• 3์ผ 1ํšŒ + 3๋ฐ• 4์ผ 1ํšŒ + ์™ธ๋ž˜ 4ํšŒ

์ œ 1๊ธฐ

์ž…์›์ผ (-1D)

2026๋…„ 09์›” 08์ผ

(์˜คํ›„ 5์‹œ๊ฒฝ ์ž…์›)

ํˆฌ์•ฝ์ผ (1D)

2026๋…„ 09์›” 09์ผ

(์ž…์›)

์ œ 2๊ธฐ

ํ‡ด์›์ผ (2D)

2026๋…„ 09์›” 10์ผ

(์˜ค์ „ 8์‹œ๊ฒฝ ์ผ์ • ์ง„ํ–‰ ํ›„ ๊ท€๊ฐ€)

๋ฐฉ๋ฌธํˆฌ์•ฝ์ผ (3D)

2026๋…„ 09์›” 11์ผ

(์˜ค์ „ 7์‹œ๊ฒฝ ์™ธ๋ž˜๋ฐฉ๋ฌธ ์ผ์ • ์ง„ํ–‰ ํ›„ ๊ท€๊ฐ€)

๋ฐฉ๋ฌธํˆฌ์•ฝ์ผ (4D)

2026๋…„ 09์›” 12์ผ

(์˜ค์ „ 7์‹œ๊ฒฝ ์™ธ๋ž˜๋ฐฉ๋ฌธ ์ผ์ • ์ง„ํ–‰ ํ›„ ๊ท€๊ฐ€)

๋ฐฉ๋ฌธํˆฌ์•ฝ์ผ (5D)

2026๋…„ 09์›” 13์ผ

(์˜ค์ „ 7์‹œ๊ฒฝ ์™ธ๋ž˜๋ฐฉ๋ฌธ ์ผ์ • ์ง„ํ–‰ ํ›„ ๊ท€๊ฐ€)

์ž…์›์ผ (5D)

2026๋…„ 09์›” 13์ผ

(์˜คํ›„ 5์‹œ๊ฒฝ ์ž…์›)

ํˆฌ์•ฝ์ผ (6D)

2026๋…„ 09์›” 14์ผ

(์ž…์›)

์ œ3๊ธฐ

ํˆฌ์•ฝ์ผ (7D)

2026๋…„ 09์›” 15์ผ

(์ž…์›)

ํ‡ด์›์ผ (8D)

2026๋…„ 09์›” 16์ผ

(์˜ค์ „ 8์‹œ๊ฒฝ ์ผ์ • ์ง„ํ–‰ ํ›„ ๊ท€๊ฐ€)

์ข…๋ฃŒ๋ฐฉ๋ฌธ

(PSV)

2026๋…„ 09์›” 21์ผ

 (1ํšŒ ์™ธ๋ž˜๋ฐฉ๋ฌธ ์ผ์ • ์ง„ํ–‰ ํ›„ ๊ท€๊ฐ€)

MediCLEO (CLEO) safely and transparently connects participants with clinical and bioequivalence trials. See ongoing trials at a glance and apply with ease.

์ŠคํŽ˜๋กœ ์ฃผ์‹ํšŒ์‚ฌ ยท CEO ์กฐ๋ฏธํ˜„ ยท ์„œ์šธํŠน๋ณ„์‹œ ๋งˆํฌ๊ตฌ ์–‘ํ™”๋กœ 19, 4์ธต(ํ•ฉ์ •๋™, ํ•ฉ์ •์˜คํ”ผ์Šค๋นŒ๋”ฉ)

Business Registration No. 367-86-01018 ยท Tel 010-2604-0216

ยฉ 2026 ๋ฉ”๋””ํด๋ ˆ์˜ค. Participation in a clinical trial should be decided voluntarily after a full explanation.